Chronic Low Back Pain Clinical Trial
Official title:
The Impact of Epidural Steroid Analgesia on Functional MRI for Patients With Low Back Pain
Chronic low back pain (CLBP) is the most prevalent form of chronic pain, and the most common
reason for disability in working-age population [2]. CLBP has also been reported associated
with many abnormal brain anatomy and function which includes the reduction in cortical gray
matter in the bilateral dorsolateral prefrontal cortex (DLPFC), thalamus, brain stem, primary
somatosensory cortex, and posterior parietal cortex. [3-5] There are already many studies
that demonstrated abnormal cortical function for people with CLBP [6-10]. Meanwhile, DLPFC
was also reported to be influenced by many pain process which included pain modulation
[11-13], placebo analgesia [14, 15], pain control [16, 17]or pain catastrophizing[18]. And
recent report has showed that effective treatment of chronic back pain patients reverses
abnormal DLPFC function[19]. Meanwhile, epidural steroid injection has been performed in
clinical for routinely managed for low back pain patients. Patients refused or have no
indication for surgery or have little response to rehabilitation may consider this
management. There was good evidence for short- and long-term relief of chronic pain secondary
to disc herniation with local anesthetic and steroids[20, 21]. However, the impact of this
treatment on functionalMRI (fMRI) has never been investigated. The investigators research
will try to solve this issue.
This study will provide a good relationship for the pain fMRI image in brain after local
lumbar spine management. And the investigators also want to perform the first data that
showed local lumbar analgesia have the impact on brain image change.
Pain, as an ancient enemy to human kind, was one of the most mystical phenomena within our
body. For centuries, people search the magic wand to solve this issue and reach the heaven
destination. However, like our original sin commit by Adam and Eve, the shadow of pain always
surround and even rebel our body and spirit. Even more, pain traps our soul and body not only
for the acute stage induced by noxious stimulation but also change our mind and body whenever
chronic period start even the stimulation disappears. Chronic pain so far has become one of
the greatest health issues for modern people. Chronic pain affects millions of people and the
treatment options are quite limited and not effective everyone[1]. On the other way, why and
how people develop chronic pain, especially when there is no further painful stimulation,
remain to be investigated.
Chronic low back pain (CLBP) is the most prevalent form of chronic pain, and the most common
reason for disability in working-age population [2]. CLBP has also been reported associated
with many abnormal brain anatomy and function which includes the reduction in cortical gray
matter in the bilateral dorsolateral prefrontal cortex (DLPFC), thalamus, brain stem, primary
somatosensory cortex, and posterior parietal cortex. [3-5] There are already many studies
that demonstrated abnormal cortical function for people with CLBP [6-10]. Meanwhile, DLPFC
was also reported to be influenced by many pain process which included pain modulation
[11-13], placebo analgesia [14, 15], pain control [16, 17]or pain catastrophizing[18]. And
recent report has showed that effective treatment of chronic back pain patients reverses
abnormal DLPFC function[19]. Meanwhile, epidural steroid injection has been performed in
clinical for routinely managed for low back pain patients. Patients refused or have no
indication for surgery or have little response to rehabilitation may consider this
management. There was good evidence for short- and long-term relief of chronic pain secondary
to disc herniation with local anesthetic and steroids[20, 21]. However, the impact of this
treatment on functionalMRI (fMRI) has never been investigated. The investigators research
will try to solve this issue.
Patients who first visited in pain clinic for low back pain with root sign will be included
in this study.
Inclusion Criteria: 1. Patients with disc herniation or radiculitis who are over 18 years of
age. 2. Patients with a history of chronic function-limiting low back pain and lower
extremity pain for at least one months' duration. 3. Patients who are competent to understand
the study and provide written informed consent and participate in outcome measurements.
Exclusion Criteria: Patients have previous lumbar surgery with metal instrument. Initial MRI
shows spinal stenosis or without disc herniation. Patients have unstable opioid use,
uncontrolled psychiatric disorders, uncontrolled acute medical illness, any condition that
could interfere with the interpretation of outcome assessments, pregnant or lactating women
or allergy to local anesthetics or steroid. Patients who are unable to perform MRI or fMRI
will also be excluded.
Pre-enrollment evaluation included demographic data, medical and surgical history with
coexisting disease, lumbar spine X-ray will also be performed.
After physical neurological examinations, pain questionnaire will be applied for initial pain
evaluation which includes pain intensity and character and physical activity and emotion
influence form their pain. Patients then will be performed the first MRI/fMRI study (with the
MRI informed consent, appendix B) for their lumbar spine and brain condition. Anyone who
don't have shown spine problem will be excluded for epidural steroid injection. After
patients' MRI/fMRI evaluation, caudal epidural steroid injection (Regiment: 0.2% lidocaine
plus kenacort 40 mg for 20 ml,) will then be performed in pain therapy room ( with the
Epidural informed consent, appendix C). Caudal epidural block will be performed 2-3 times
with 2 week interval to reach optimal analgesia. The pain condition will be followed every
month with pain questionnaire for up 3 month. The secondary MRI/fMRI will then be performed 3
months later after the first caudal epidural steroid injection.
MRI scans will be acquired on a 3T scanner in NCKU. The special technician will help us and
the patient for MRI scan and the setting of all MRI parameter. Dr. Sun and a qualified
radiologist will help for data analysis after MRI performance. The investigators will also
follow the method that described before[19]: An anatomical scan will be acquired at the
beginning of the session and lasted 5 min. The following parameters will be used: echo time
(TE) 3 ms, repetition time (TR) 2.3 s, flip angle 9。, resolution 1*1*1 mm. During a
functional scan of ~5 min, subjects will perform the Multi-Source Interference Task as
previous reported[22, 23]. The task stimuli will be presented on a screen in the subjects'
view while lying in the MRI scanner, and subjects will respond on a three-button response
box. The task has three levels of difficulty, a motor control task, and easy level and a
difficult level. The task will enhance the brain network if pain persistent[23]. The
parameters for functional scan were as follow: echo-planar imaging, TE 3 ms, TR 2.26s, flip
angle 90。, 128 frames, 64*64 matrix, 38 slices for whole-brain coverage, resolution 4*4*4 mm.
Images were acquired in the axial plane, plus 30。 from the anterior commissure-posterior
commissure line to avoid the eyes. The fMRI data analysis will be help under our university
team.
Total patients number will be calculated on the basis of significant pain relief and set as
33 patients with the following statistic parameter: α: 0.05(type I error probability), power
0.8(probability of correctly rejecting the null hypothesis), δ:0.5(difference in population
means), σ:1(standard deviation of difference). 20 % noncompliance rate was added and total 40
patients will be included in this study. According to previous report, 20 more low back
patients (oral pain control drug plus rehab and refuse epidural steroid injection) were
needed to include for twice MRI survey.[19]
Statistical analysis will include the chi-square, Fisher exact test, t test and paired t
test. The chi-square will be used to test the difference in proportions. Fisher exact test
will be for whatever the expected value is less than 5; paired t test will used for comparing
the pre-and post-treatment results. For comparison of mean between groups, t test will be
done. All the data will be presented as mean ± SEM, and P < 0.05 will be considered
statistically significant in all cases.
This study will provide a good relationship for the pain fMRI image in brain after local
lumbar spine management. And the investigators also want to perform the first data that
showed local lumbar analgesia have the impact on brain image change.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03243084 -
Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy
|
N/A | |
Suspended |
NCT04735185 -
Stem Cells vs. Steroids for Discogenic Back Pain
|
N/A | |
Completed |
NCT03162952 -
RAND Center of Excellence for the Study of Appropriateness of Care in CAM
|
||
Completed |
NCT03240146 -
Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain
|
N/A | |
Completed |
NCT05282589 -
Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients
|
N/A | |
Completed |
NCT03637998 -
Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT02289170 -
Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)
|
N/A | |
Active, not recruiting |
NCT01944163 -
The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain
|
N/A | |
Completed |
NCT02231554 -
Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT02063503 -
Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients
|
N/A | |
Terminated |
NCT01620775 -
MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain
|
N/A | |
Completed |
NCT01704677 -
Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up
|
N/A | |
Completed |
NCT01490905 -
A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain
|
Phase 4 | |
Completed |
NCT01177241 -
Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids
|
N/A | |
Completed |
NCT01177254 -
Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
|
N/A | |
Completed |
NCT01177280 -
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes
|
N/A | |
Completed |
NCT00984815 -
Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment
|
Phase 3 | |
Completed |
NCT00763321 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
Completed |
NCT00761150 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
Completed |
NCT00767806 -
A Study for Patient With Chronic Low Back Pain
|
Phase 3 |